Sign in
4/A

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0000899243-18-000531

Director acquired 16,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Billings Paul · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 1 in the form +16,667 23,165 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-01-02 Exercise or conversion : show line 2 in the form Restricted Stock Units −16,667 0 D
Loading xslF345X03/doc4a.xml…